JAGX JAGUAR HEALTH INC Capital Structure Changes 8-K Filing 2025 - Equity Offerings On May 13, 2025, Jaguar Health, Inc. executed exchange agreements with Iliad and Streeterville involving the issuance of shares of common and preferred stock in exchange for a reduction of outstanding royalty interests totaling approximately $1,016,200. Additionally, it formalized the creation of Series L Preferred Stock, which will not pay dividends and has specific voting rights effective from May 14, 2025.Get access to all SEC 8-K filings of the JAGUAR HEALTH INC